Andrea Evinova

Dr. Andrea Evinova

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Central European Journal of Public Health
Verified
Journal Article
Closed access
SMSilvia Mahmood
Silvia Mahmood
AEAndrea Evinova
Andrea Evinova
MŠMária Škereňová
Mária Škereňová
IOIgor Ondrejka
Igor Ondrejka
JLJán Lehotský
Ján Lehotský
Major depressive disorder (MDD) is a main public health concern worldwide. Despite extensive investigations, the exact mechanisms responsible for MDD have not been identified. Epidermal growth factor (EGF) and insulin growth factor binding protein-3 (IGFBP-3) are involved in brain function. Tumour suppressor protein p53 is widely involved in neuronal death in response to different forms of acute insults and neurological disorders. The present study focuses on the possible associations of the single-nucleotide polymorphisms (SNP) of EGF A61G (rs4444903), IGFBP-3 C32G (rs2854746) and TP53 G72C (rs1042522) genes with MDD risk in the Slovak population. The present case-control association study was carried out in 111 confirmed MDD patients and 207 healthy subjects. Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism methods. Logistic regression analysis showed no association between SNPs of selected genes and MDD risk in the Slovak population. However, the stratification of individuals by gender revealed that males carrying IGFBP-3 G alleles (G32G or GG) had marginally increased risk for developing MDD as compared to CC homozygous males (p=0.09). In women, inverse association was observed between SNP rs1042522 and MDD risk (p=0.04 for recessive model). Our results suggest the protective effect of minor allele 72C of TP53 gene towards MDD. The disruption of mechanisms involved in cell survival and death regulation may be involved in pathophysiology of MDD.

1 January 2012 in General Physiology and Biophysics
Verified
Journal Article
Closed access
AEAndrea Evinova
Andrea Evinova
EBEva Babusikova
Eva Babusikova
SSStanislav Straka
Stanislav Straka
IOIgor Ondrejka
Igor Ondrejka
JLJán Lehotský
Ján Lehotský
Analysis of genetic polymorphisms of brain-derived neurotrophic factor and methylenetetrahydrofolate reductase in depressed patients in a Slovak (Caucasian) population

1 July 2017 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
EBEva Babusikova
Eva Babusikova
JJJana Jurecekova
Jana Jurecekova
MJMilos Jesenak
Milos Jesenak
AEAndrea Evinova
Andrea Evinova

5 June 2013 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
JJJana Jurečeková
Jana Jurečeková
MSMonika Kmetova Sivonova
Monika Kmetova Sivonova
AEAndrea Evinova
Andrea Evinova
JKJán Kliment
Ján Kliment
DDDušan Dobrota
Dušan Dobrota

11 June 2024 in Biomedicines
Verified
Journal Article
Open access
PPPetra Parvanovova
Petra Parvanovova
AEAndrea Evinova
Andrea Evinova
MGMilan Grofik
Milan Grofik
PHPetra Hnilicová
Petra Hnilicová
ZTZuzana Tatarkova
Zuzana Tatarkova
MKMonika Turcanova Koprusakova
Monika Turcanova Koprusakova
Amyotrophic lateral sclerosis is a severe neurodegenerative disease whose exact cause is still unclear. Currently, research attention is turning to the mitochondrion as a critical organelle of energy metabolism. Current knowledge is sufficient to confirm the involvement of the mitochondria in the pathophysiology of the disease, since the mitochondria are involved in many processes in the cell; however, the exact mechanism of involvement is still unclear. We used peripheral blood mononuclear cells isolated from whole fresh blood from patients with amyotrophic lateral sclerosis for measurement and matched an age- and sex-matched set of healthy subjects. The group of patients consisted of patients examined and diagnosed at the neurological clinic of the University Hospital Martin. The set of controls consisted of healthy individuals who were actively searched, and controls were selected on the basis of age and sex. The group consisted of 26 patients with sporadic forms of ALS (13 women, 13 men), diagnosed based on the definitive criteria of El Escorial. The average age of patients was 54 years, and the average age of healthy controls was 56 years. We used a high-resolution O2K respirometry method, Oxygraph-2k, to measure mitochondrial respiration. Basal respiration was lower in patients by 29.48%, pyruvate-stimulated respiration (respiratory chain complex I) was lower by 29.26%, and maximal respiratory capacity was lower by 28.15%. The decrease in succinate-stimulated respiration (respiratory chain complex II) was 26.91%. Our data confirm changes in mitochondrial respiration in ALS patients, manifested by the reduced function of complex I and complex II of the respiratory chain. These defects are severe enough to confirm this disease’s hypothesized mitochondrial damage. Therefore, research interest in the future should be directed towards a deeper understanding of the involvement of mitochondria and respiratory complexes in the pathophysiology of the disease. This understanding could develop new biomarkers in diagnostics and subsequent therapeutic interventions.

26 May 2014 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
MJMilos Jesenak
Milos Jesenak
EBEva Babusikova
Eva Babusikova
AEAndrea Evinova
Andrea Evinova
PBPeter Banovcin
Peter Banovcin
DDDusan Dobrota
Dusan Dobrota